Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses
General and administrative	$ 3,185,451	$ 2,434,127	$ 9,167,560	$ 6,138,528
Research and development	9,273,269	8,964,528	26,534,297	23,610,888
Total operating expenses	(12,458,720)	(11,398,655)	(35,701,857)	(29,749,416)
Other income (expenses)
Grant income		43,280		54,100
Research and development incentive income	682,432	1,363,661	2,328,675	3,593,856
Interest income, net	229,917	11,453	242,405	19,110
Foreign exchange(loss) gain, net	(732,549)	(160,880)	(408,541)	17,191
Total other income, net	179,800	1,257,514	2,162,539	3,684,257
Net loss before provision for income taxes	(12,278,920)	(10,141,141)	(33,539,318)	(26,065,159)
Income tax expense, current	(88,421)	(39,000)	(148,201)	(125,269)
Net loss and comprehensive loss	$ (12,367,341)	$ (10,180,141)	$ (33,687,519)	$ (26,190,428)
Net Loss per share
Basic and diluted	$ (0.16)	$ (0.14)	$ (0.44)	$ (0.39)
Weighted average number of shares outstanding
Basic and diluted	77,442,236	70,589,651	76,561,940	67,810,774